Privia Health Group, Inc. $PRVA Shares Purchased by Geode Capital Management LLC

Geode Capital Management LLC boosted its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 1.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,814,290 shares of the company’s stock after buying an additional 31,204 shares during the period. Geode Capital Management LLC owned 2.29% of Privia Health Group worth $66,738,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its position in Privia Health Group by 5.3% in the third quarter. Vanguard Group Inc. now owns 12,098,933 shares of the company’s stock worth $301,263,000 after buying an additional 607,447 shares during the period. Durable Capital Partners LP grew its stake in shares of Privia Health Group by 1.8% in the third quarter. Durable Capital Partners LP now owns 11,691,685 shares of the company’s stock worth $291,123,000 after purchasing an additional 203,842 shares in the last quarter. State Street Corp grew its stake in shares of Privia Health Group by 1.5% in the second quarter. State Street Corp now owns 4,171,069 shares of the company’s stock worth $95,935,000 after purchasing an additional 61,853 shares in the last quarter. Van Berkom & Associates Inc. grew its stake in shares of Privia Health Group by 1.8% in the fourth quarter. Van Berkom & Associates Inc. now owns 3,844,256 shares of the company’s stock worth $91,147,000 after purchasing an additional 69,691 shares in the last quarter. Finally, Principal Financial Group Inc. grew its stake in shares of Privia Health Group by 1.6% in the fourth quarter. Principal Financial Group Inc. now owns 2,787,802 shares of the company’s stock worth $66,099,000 after purchasing an additional 43,589 shares in the last quarter. 94.48% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Privia Health Group news, CEO Parth Mehrotra sold 15,647 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $22.64, for a total transaction of $354,248.08. Following the completion of the sale, the chief executive officer directly owned 434,357 shares in the company, valued at approximately $9,833,842.48. This trade represents a 3.48% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO David Mountcastle sold 3,385 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $22.60, for a total value of $76,501.00. Following the sale, the chief financial officer owned 211,462 shares of the company’s stock, valued at $4,779,041.20. The trade was a 1.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 256,445 shares of company stock worth $5,769,000. 5.70% of the stock is currently owned by company insiders.

Privia Health Group Trading Down 1.0%

Shares of NASDAQ PRVA opened at $21.41 on Tuesday. Privia Health Group, Inc. has a one year low of $18.77 and a one year high of $26.51. The firm has a market capitalization of $2.70 billion, a PE ratio of 133.82, a PEG ratio of 1.56 and a beta of 0.90. The business has a 50-day moving average price of $22.66 and a two-hundred day moving average price of $22.96.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.11. Privia Health Group had a return on equity of 2.81% and a net margin of 0.97%.The firm had revenue of $603.85 million during the quarter, compared to analyst estimates of $560.99 million. During the same period last year, the company posted $0.22 EPS. The business’s quarterly revenue was up 25.8% compared to the same quarter last year. Research analysts anticipate that Privia Health Group, Inc. will post 0.29 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have recently issued reports on PRVA shares. Canaccord Genuity Group decreased their price target on Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, May 8th. Jefferies Financial Group reissued a “buy” rating and issued a $32.00 price target on shares of Privia Health Group in a research note on Thursday, February 26th. Weiss Ratings cut Privia Health Group from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. Barclays decreased their price target on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 26th. Finally, Truist Financial increased their price target on Privia Health Group from $31.00 to $33.00 and gave the stock a “buy” rating in a research note on Monday, March 2nd. Eleven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $31.15.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.